Scholar Rock is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO David L. Hallal, with a market cap of $5.7B.
Common questions about Scholar Rock
Scholar Rock is scheduled to report earnings for Q1 2026 on May 13, 2026. Analysts estimate revenue of $4.0M.
Scholar Rock has approximately 150 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.